Related references
Note: Only part of the references are listed.Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302
Jonathan W. Wojtkowiak et al.
CANCER & METABOLISM (2015)
Oncogenic KRAS signalling in pancreatic cancer
S. Eser et al.
BRITISH JOURNAL OF CANCER (2014)
A proinvasive role for the Ca2+-activated K+ channel KCa3.1 in malignant glioma
Kathryn L. Turner et al.
GLIA (2014)
Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?
Nelma Pertega-Gomes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Comprehensive measurement of respiratory activity in permeabilized cells using extracellular flux analysis
Joshua K. Salabei et al.
NATURE PROTOCOLS (2014)
Mitochondrial ion channels as oncological targets
L. Leanza et al.
ONCOGENE (2014)
Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment
Anne Poder Andersen et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
KRAS: feeding pancreatic cancer proliferation
Kirsten L. Bryant et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Hypoxia-inducible factor (HIF) network: insights from mathematical models
Miguel A. S. Cavadas et al.
CELL COMMUNICATION AND SIGNALING (2013)
Molecular basis of potassium channels in pancreatic duct epithelial cells
Mikio Hayashi et al.
CHANNELS (2013)
Targeting lactate metabolism for cancer therapeutics
Joanne R. Doherty et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Gregg L. Semenza
JOURNAL OF CLINICAL INVESTIGATION (2013)
Understanding pancreatic cancer genomes
Mark J. Cowley et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2013)
Inhibitory effects of blockage of intermediate conductance Ca2+-activated K+ channels on proliferation of hepatocellular carcinoma cells
Xiao-wei Yang et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2013)
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Jaekyoung Son et al.
NATURE (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
An intermediate-conductance Ca2+-activated K+ channel is important for secretion in pancreatic duct cells
Mikio Hayashi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia
Mitsuro Kanda et al.
GASTROENTEROLOGY (2012)
Dynamic redistribution of calcium sensitive potassium channels (hKCa3.1) in migrating cells
Albrecht Schwab et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma
Nardin Samuel et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. De Nicola et al.
NATURE (2011)
Cloning and identification of tissue-specific expression of KCNN4 splice variants in rat colon
Christian Barmeyer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
An investigation of the occurrence and properties of the mitochondrial intermediate-conductance Ca2+-activated K+ channel mtK(Ca)3.1
Nicola Sassi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2010)
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
John P. Morris et al.
NATURE REVIEWS CANCER (2010)
Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis
Maria A. Lebedeva et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2009)
Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?
Michel Feletou
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Intermediate conductance Ca2+-activated potassium channel (KCa3.1) in the inner mitochondrial membrane of human colon cancer cells
Umberto De Marchi et al.
CELL CALCIUM (2009)
A nucleocytoplasmic malate dehydrogenase regulates p53 transcriptional activity in response to metabolic stress
S. M. Lee et al.
CELL DEATH AND DIFFERENTIATION (2009)
KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?
Chuan-Chu Chou et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2008)
The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans
Kazuyoshi Toyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Ca2+-activated K+ channels in murine endothelial cells:: Block by intracellular calcium and magnesium
Jonathan Ledoux et al.
JOURNAL OF GENERAL PHYSIOLOGY (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
p53 regulates mitochondrial respiration
Satoaki Matoba et al.
SCIENCE (2006)
International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels
AD Wei et al.
PHARMACOLOGICAL REVIEWS (2005)
K-ras codon-specific mutations produce distinctive metabolic phenotypes in human fibroblasts
P Vizan et al.
CANCER RESEARCH (2005)
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
RG Jones et al.
MOLECULAR CELL (2005)
IKCa-channel blockers.: Part 2:: Discovery of cyclohexadienes
K Urbahns et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression
F Schwartzenberg-Bar-Yoseph et al.
CANCER RESEARCH (2004)
Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro
H Jäger et al.
MOLECULAR PHARMACOLOGY (2004)
Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells
R Rossignol et al.
CANCER RESEARCH (2004)
Regulation of PTEN transcription by p53
V Stambolic et al.
MOLECULAR CELL (2001)
Share Paper
